DELAYS in treatment, as a result of the coronavirus disease (COVID-19) pandemic, have been experienced by many people with cancer across the world.

Major noncardiac surgery leads to development of one or more heart complications within a year for one in five patients.

SARS-CoV-2 infection in patients with congenital heart disease (CHD) is associated with a low risk of moderate or severe coronavirus disease

The ESC Congress 2020 presented several promising clinical trials that may potentially change our practice in heart failure management.

LONG-TERM use of proton pump inhibitors (PPI) has been linked to increased risk of Type 2 diabetes mellitus (T2DM), in a large-scale, observational…

ROBOTICS guidance for colonoscopy may not be far away, following progress in the development of a semi-autonomous procedure. After 12 years of…

MICROBIOTA of the gut, which have a profound influence on the host’s body functions, can be restored through faecal transplantation in infants born through caesarean section (C-section).

REPLICATION of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been shown to be inhibited by an antiviral medication approved in the treatment against multiple sclerosis in vitro.

VACCINES against melanoma could be developed after new research has identified human leukocyte antigen (HLA)-peptides as unique markers for melanoma.

WOUND treatment and prevention of the skin ageing process could be aided by a newly discovered genetic factor.